To investigate the molecular mechanisms by which BNC1 exerts its tumor-suppressive effects, the study employed an integrative approach combining transcriptome sequencing, bioinformatics analyses, and cellular functional assays to identify and validate C-C motif chemokine ligand 20 (CCL20) as a downstream target gene of BNC1. This evidence concerns the gene CCL20 and neoplasm.